aTyr Pharma, Inc
Price
FilingsNewest: 8-K, Other eventsSep 24 →Insiders1 insider bought $962,720 in 3 open-market buys. 3 insiders sold $6,293, 0 of 3 sales on a 10b5-1 plan.→HoldersFederated Hermes 8.7%Vanguard 3.9%Kalehua 3.6%→Financing →PeersClosest companies: DSGN, ORIC, IMRX→
From the filings
Figures
- Revenue
- $190,000last 12 months
- Net income
- −$60.8Mlast 12 months
- Operating cash flow
- −$59.1Mlast 12 months
- Cash and equivalents
- $16.2Mat the last balance sheet
- Shares outstanding
- 98.1M shareson issue